English | Español
Press release submission | Mar 31, 2021

SANOFI: FDA approves Sarclisa® (isatuximab-irfc) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma
Press release submission | Mar 18, 2021

Pack Health and National Multiple Sclerosis Society Announce Partnership to Support Patients with MS
Press release submission | Mar 10, 2021

LINNAEUS THERAPEUTICS: Granted Orphan Drug Designation for LNS8801 for the Treatment of Patients with Metastatic Uveal Melanoma
Press release submission | Feb 25, 2021

EVERSANA: Launches Chronic Disease Real-World Data Solution Covering More Than 80 Million Deidentified Patients to Drive Regulatory-Grade Clinical Research and Improve Patient Outcomes
Press release submission | Feb 4, 2021

CDI: Commonwealth Diagnostics International, Inc.'s IBSchek® Granted PLA Code from AMA; Company to Now Accept Insurance, Providing More Patients At-Home Access
Benjamin Kibbey | Jan 7, 2021

Average U.S. life expectancy rose prior to COVID-19 pandemic
Press release submission | Jan 2, 2021

REGENERON: Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen
Press release submission | Jan 2, 2021

U.S. RENAL CARE: To Administer IV Monoclonal Antibody Therapy in Dialysis Clinics to Confirmed COVID-19 Patients

Trending
Patient Daily | Jul 8, 2025

Clinical assistant professor at Stanford: ‘Musical background is associated with better performance of fundamental surgical skills'
Patient Daily | Jul 9, 2025

FDA approves Longeveron's Phase 2 study for pediatric dilated cardiomyopathy treatment
+ Pharmaceuticals
Patient Daily | Jul 8, 2025

Psychedelic mushrooms' compound shows potential antiaging effects